NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
Written | 2002-01 | Fei Chen |
Health Effects Laboratory Division, NIOSH, 1095 Willowdale Rd, Morgantown, WV 26505, USA |
(Note : for Links provided by Atlas : click)
1. Identity
Alias_names | General Information |
Alias_symbol (synonym) | LYT-10 |
p52 | |
p105 | |
NF-kB2 | |
p49/p100 | |
Other alias | NF-kB p100 |
NF-kB p52 | |
Lyt10 | |
HGNC (Hugo) | NFKB2 |
LocusID (NCBI) | 4791 |
Atlas_Id | 362 |
Location | 10q24.32 [Link to chromosome band 10q24] |
Location_base_pair | Starts at 102395596 and ends at 102402529 bp from pter ( according to hg19-Feb_2009) [Mapping NFKB2.png] |
Fusion genes (updated 2017) | Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands) |
GPI (19q13.11) / NFKB2 (10q24.32) | NFKB2 (10q24.32) / GBF1 (10q24.32) | NFKB2 (10q24.32) / INA (10q24.33) | |
NFKB2 (10q24.32) / NEURL1 (10q24.33) | NFKB2 (10q24.32) / TBXAS1 (7q34) | PFKL (21q22.3) / NFKB2 (10q24.32) | |
SPATA48 (7p12.2) / NFKB2 (10q24.32) | STPG1 (1p36.11) / NFKB2 (10q24.32) |
Note | see also, in the Deep Insight section: Upstream Signal Transduction of NF-kB Activation |
2. DNA/RNA
Description | The gene encoding human nfkb2 has 24 exons spanning 8 kb. The expression of nfkb2 can be regulated by two distinct promoters, P1 and P2, in which a number of consensus binding sites for transcription factors, including SP1, AP1 and putative NF-kappa B (kappa B sites), were identified. |
3. Protein
![]() | |
Description | The human nfkb2 gene encodes a protein composed 900 amino acids with an approximately molecular weight of 100 kDa, which was considered as a precursor of p52 subunit of NF-kB complexes. The structural characteristics of NF-kB2 are much similar with that of NF-kB1: A N-terminal RHD; two nuclear localization sequences within the C-terminus of RHD, a putative GRR region that possibly contributes to the generation of NF-kB p52 from the precursor, NF-kB2. The C-terminal region of NF-kB2 also contains multiple copies of the so-called ankyrin repeats and one proline, glutamic acid, serine, and threonine (PEST) domain. Studies demonstrated that NF-kB2 was posttranslationally cleaved to produce the p52 molecule through the ubiquitin-proteasome dependent degradation of the C-terminal 406-900 portion of NF-kB2. However, other studies revealed that the mechanism for the generation of NF-kB p52 is through cotranslational processing. Recent studies demonstrated that the processing of NF-kB p52 required IKKa- and/or NIK-dependent C-terminal phosphorylation of NF-kB2. |
Expression | nfkb2 is expressed mainly in lymphoid cells and mononuclear cells. |
Localisation | cytosol, nuclei after activation. |
Function | regulation of the genes involved in cell-to-cell interaction, intercellular communication, cell recruitment or transmigration, amplification or spreading of primary pathogenic signals, and initiation or acceleration of tumorigenesis. Similar with NF-kB1, the full length of NF-kB2 can serve as an endogenous inhibitor for the NF-kB p50/ p65(RelA) or NF-kB p52/p65 heterodimer. The homodimer of NF-kB p52 was transcriptionally inactive in the absence of Bcl3. Furthermore, the NF-kB p52 homodimer may function to competitively inhibit B binding by transactivating NF- B dimers. The Bcl3 protein can form a complex with this homodimer at B sites and act as a transactivator of NF-kB p52 homodimer. Interaction with : members of IkB family and Rel family, Bcl3. |
4. Implicated in
Note | |
Entity | hematological malignancies (see below) and other diseases: autoimmune arthritis, glomerulonephritis, asthma, inflammatory bowel disease, septic shock, lung fibrosis, cancer, HTLV-1 infection, and AIDS. |
Disease | t(10;14)(q24;q11) or t(10;14)(q24;q32) in hematological malignancies |
Cytogenetics | poor. |
Oncogenesis | Unlike its relative nfkb1, rearrangement of nfkb2 gene locus has been found in many forms of lymophomas. The chromosomal translocations by t(10;14)(q24;q11) and t(10;14)(q24;q32) cause deletions of sequences encoding the ankyrin repeat motif of NF-kB2. Consequently, this carboxyl terminal truncated NF-kB2 is constitutively located in the nucleus of cells, which was found in small percentage of B-cell non-Hodgkin's lymphoma, cutaneous lymphomas, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemias, and multiple myelomas. Chromosomal translocation generated a fusion NF-kB2- IGHA1 or NF-kB2- TCRa or TCRd transcriptional unit. |
5. Bibliography
The NF-kappa B and I kappa B proteins: new discoveries and insights. |
Baldwin AS Jr |
Annual review of immunology. 1996 ; 14 : 649-683. |
PMID 8717528 |
New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. |
Chen F, Castranova V, Shi X, Demers LM |
Clinical chemistry. 1999 ; 45 (1) : 7-17. |
PMID 9895331 |
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. |
Ghosh S, May MJ, Kopp EB |
Annual review of immunology. 1998 ; 16 : 225-260. |
PMID 9597130 |
The generation of nfkb2 p52: mechanism and efficiency. |
Heusch M, Lin L, Geleziunas R, Greene WC |
Oncogene. 1999 ; 18 (46) : 6201-6208. |
PMID 10597218 |
Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. |
Liptay S, Schmid RM, Perkins ND, Meltzer P, Altherr MR, McPherson JD, Wasmuth JJ, Nabel GJ |
Genomics. 1992 ; 13 (2) : 287-292. |
PMID 1612589 |
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. |
Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R |
Cell. 1991 ; 67 (6) : 1075-1087. |
PMID 1760839 |
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. |
Senftleben U, Cao Y, Xiao G, Greten FR, Krähn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M |
Science (New York, N.Y.). 2001 ; 293 (5534) : 1495-1499. |
PMID 11520989 |
Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. |
Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, Waterfield M, Sun SC |
The EMBO journal. 2001 ; 20 (23) : 6805-6815. |
PMID 11726516 |
6. Citation
This paper should be referenced as such : |
Chen, F |
NFKB2 (nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) |
Atlas Genet Cytogenet Oncol Haematol. 2002;6(2):98-99. |
Free journal version : [ pdf ] [ DOI ] |
On line version : http://atlasgeneticsoncology.usal.es/classic/Genes/NFKB2ID362.html |
7. Other Leukemias implicated (Data extracted from papers in the Atlas) [ 4 ]
t(10;14)(q24;q32) NFKB2/IGH
t(6;10)(q22;q24) NFKB2/ROS1 t(10;14)(q24;q32) IGH/NFKB2 t(10;19)(q24;p13) NFKB2/TYK2 |
Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 1 ] |
NFKB2/GBF1 (10q24)
|
8. External links
REVIEW articles | automatic search in PubMed |
Last year publications | automatic search in PubMed |
© Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Thu Jan 17 19:02:37 CET 2019 |
For comments and suggestions or contributions, please contact us atlasgeneticsoncology@usal.es.